Kyverna Therapeutics reports positive 1-year KYSA-8 trial data for miv-cel in stiff person syndrome
Bitget2026/10/07 12:02Kyverna Therapeutics flagged new one-year results from its KYSA-8 registrational trial of miv-cel in stiff person syndrome. Data will be presented at MSToronto2026 on Oct. 21, 2026, pointing to sustained clinical benefit with a well-tolerated safety profile. Updated Phase 1 investigator-initiated findings in progressive multiple sclerosis will be presented on Oct. 23, 2026, showing encouraging early activity. Management indicated it is working to complete a BLA in its initial indication this quarter, a key step toward a potential first approval. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070800PRIMZONEFULLFEED9841094) on October 07, 2026, and is solely responsible for the information contained therein.
- Kyverna Therapeutics flagged new one-year results from its KYSA-8 registrational trial of miv-cel in stiff person syndrome.
- Data will be presented at MSToronto2026 on Oct. 21, 2026, pointing to sustained clinical benefit with a well-tolerated safety profile.
- Updated Phase 1 investigator-initiated findings in progressive multiple sclerosis will be presented on Oct. 23, 2026, showing encouraging early activity.
- Management indicated it is working to complete a BLA in its initial indication this quarter, a key step toward a potential first approval.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66